Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-02-08FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (CIPLA USA INC.,)
FDA approved a supplemental application for Bupropion hydrochloride submitted by Cipla USA Inc., reflecting a regulatory action on an existi…
-
FDA approval · 2023-02-07FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Cadila Pharmaceuticals Limited)
FDA approved a supplemental application for bupropion hydrochloride submitted by Cadila Pharmaceuticals Limited.
-
FDA approval · 2023-01-25FDA Approved: VARENICLINE — Original Application (Apotex Corp)
The FDA approved Apotex Corp's generic varenicline under an Original Abbreviated New Drug Application for smoking-cessation use.
-
FDA approval · 2022-12-21FDA Approved: NICOTINE POLACRILEX GUM — Original Application (Fertin Pharma A/S)
FDA approved Fertin Pharma A/S's Nicotine Polacrilex Gum as an original application for the treatment of nicotine dependence and to aid smok…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior [NA]
Clinical trial evaluating the impact of nicotine messaging on nicotine beliefs and tobacco use behavior has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: AXS-05 Phase II Trial on Smoking Behavior [Phase 2]
Phase 2 trial update for AXS-05 in smoking cessation shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Families With Substance Use and Psychosis: A Pilot Study [NA]
A completed pilot study from McLean Hospital investigating families with substance use and psychosis; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking [NA]
Completed clinical trial evaluating smartphone-delivered attentional bias modification training to help patients quit smoking; results poste…
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Accelerated iTBS in Smoking Cessation [NA]
Clinical trial completed evaluating accelerated iTBS for nicotine dependence and smoking cessation, with results posted in 2022.
-
FDA approval · 2022-09-02FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for bupropion hydrochloride from Epic Pharma LLC, indicating approval of a generic formulation.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: E-cigarette Nicotine Study [Phase 2]
Phase 2 clinical trial update on an e-cigarette nicotine study focusing on nicotine dependence and electronic cigarette use.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Translational Neuropsychopharmacology Research of Nicotine Addiction [Phase 2]
Phase 2 clinical trial update for translational neuropsychopharmacology research of nicotine addiction completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: TMS-fMRI for Neural Pathway in Smokers [NA]
A terminated clinical trial investigating TMS-fMRI to study neural pathways in nicotine dependence; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: Progesterone and Brain Imaging Study [Phase 4]
Phase 4 clinical trial update on progesterone and brain imaging for nicotine dependence and withdrawal completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products [Phase 2]
Phase 2 clinical trial evaluating how nicotine dose and delivery route in e-cigarettes affect adoption and exposure to toxic combustion prod…
-
CLINICAL_TRIALS research · 2022-06-28Clinical Trial Update: Community Intervention to Reduce Tobacco Use in Pregnant Women [NA]
A completed clinical trial evaluating a community intervention aimed at reducing tobacco use among pregnant women.
-
FDA approval · 2022-06-23FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Slate Run Pharmaceuticals, LLC)
The FDA approved a supplemental application for a generic Bupropion hydrochloride sustained-release product from Slate Run Pharmaceuticals, …
-
FDA approval · 2022-05-13FDA Approved: AMAZON BASIC CARE NICOTINE POLACRILEX — Original Application (Amazon.com Services LLC)
FDA approved the original application for Amazon Basic Care Nicotine Polacrilex Mini, a nicotine replacement product intended to aid smoking…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Comparing NicoBloc to Nicotine Lozenges [Phase 2, Phase 3]
A Phase 2/3 clinical trial comparing NicoBloc to nicotine lozenges has completed, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Do Flavors Increase the Addiction Potential of Nicotine? [Phase 2]
A Phase 2 clinical trial evaluating whether flavors increase the addiction potential of nicotine; completed study on nicotine dependence.
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Babies Living Safe and Smokefree [NA]
A completed clinical trial update related to reducing secondhand tobacco smoke exposure and nicotine dependence, with results posted in 2022…
-
FDA approval · 2022-03-04FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Sam's West Inc)
The FDA approved a supplemental application for the Nicotine Transdermal System (nicotine patch) submitted by Sam's West Inc. This action co…
-
FDA approval · 2022-02-02FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Bupropion hydrochloride as an original-application generic product by Granules Pharmaceuticals Inc.; the product is indicated f…
-
CLINICAL_TRIALS research · 2022-01-12Clinical Trial Update: Reducing Tobacco Use Disparities Among Low-Income Adults [NA]
Clinical trial update on reducing tobacco use disparities among low-income adults; study completed with results posted.
-
FDA approval · 2022-01-06FDA Approved: TOPCARE NICOTINE — Supplemental Application (Topco Associates LLC)
FDA approved a supplemental application for TOPCARE NICOTINE (nicotine polacrilex) from Topco Associates LLC.